New quadrivalent flu vaccine trial for infants shows promise
NCT ID NCT04381689
First seen Mar 26, 2026 · Last updated May 15, 2026 · Updated 6 times
Summary
This study tests a new quadrivalent seasonal flu vaccine in healthy infants aged 6 months to under 3 years. The goal is to see if the vaccine is safe and triggers a strong immune response. About 245 infants will receive either the new vaccine or an existing one, and their antibody levels will be measured.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Korea University ANSAN Hospital
Ansan-si, Gyeonnggi-do, 15355, South Korea
-
The Catholic University of Korea, Bucheon St. Mary's Hospital
Bucheon-si, Gyeonnggi-do, 15355, South Korea
Conditions
Explore the condition pages connected to this study.